{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:39:39Z","timestamp":1792510779375,"version":"4.5.0"},"reference-count":125,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Duhuo-Jisheng decoction (DJD) is a Chinese herb formula. Previous studies have reported that the clinical symptoms and laboratory indicators of rheumatoid arthritis (RA) patients could be improved by DJD. However, the existing evidence was not robust enough and controversial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Randomized controlled trials of DJD for RA were retrieved from Chinese and English databases from their inception to April 16, 2023. Meta-analysis was performed by Stata 17 software. We used subgroup analysis, meta-regression, and sensitivity analysis to identify potential sources of heterogeneity. The subgroup analysis and meta-regression were conducted from 6 aspects, including age, course of disease, course of treatment, interventions used in the experimental or control group, and random sequence generation. Galbraith plot was used to find studies with possible heterogeneity. Publication bias was assessed by Egger\u2019s test and funnel plots when the number of relevant studies was greater than or equal to 10.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty-two studies were included, involving 3635 patients and 19 outcome indicators. Meta-analysis showed that, compared with the routine disease-modifying antirheumatic drugs (rDMARDs), DJD could better improve the level of laboratory indicators, main symptoms and signs, and questionnaire scores of RA patients. The laboratory indicators included rheumatoid factor, T lymphocyte subpopulation (including CD4<jats:sup>+<\/jats:sup>, CD8<jats:sup>+<\/jats:sup>, and CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup>), and inflammatory biomarkers (including erythrocyte sedimentation rate, C-reactive protein, tumor necrosis factor-\u03b1, interleukin 6, interleukin 1\u03b2, and interleukin 1). The main symptoms and signs included the duration of morning stiffness, the number of joint tenderness, the number of swollen joints, and the grip strength of both hands. The questionnaire included visual analogue scale, health assessment questionnaire, and disease activity score in 28 joints. In addition, the adverse events of DJD treatment were significantly lower than those of rDMARDs. However, the results of a few subgroup analyses differed from the overall results. Furthermore, the publication bias assessment showed that, out of 11 evaluated results, 4 had publication bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>DJD could be a satisfactory complementary and alternative therapy for RA. However, due to a small number of subgroup analysis results being different from the overall results, it should be verified by further studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035513","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:07:32Z","timestamp":1701162452000},"page":"e35513","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of Duhuo-Jisheng decoction in rheumatoid arthritis: A systematic review and meta-analysis of 42 randomized controlled trials"],"prefix":"10.1097","volume":"102","author":[{"given":"Pengda","family":"Qu","sequence":"first","affiliation":[{"name":"First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Wang","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Du","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaorong","family":"Peng","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Hu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8215-4078","authenticated-orcid":false,"given":"Xiaohu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0000000000000664","article-title":"Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages.","volume":"32","author":"Coutant","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(16)30363-4","article-title":"Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.","volume":"388","author":"Bijlsma","year":"2016","journal-title":"Lancet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"9882","DOI":"10.1038\/s41598-020-66945-3","article-title":"Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis.","volume":"10","author":"Sato","year":"2020","journal-title":"Sci Rep"},{"key":"R4-20250504","first-page":"1024","article-title":"Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases.","volume":"17","author":"B\u0103l\u0103nescu","year":"2019","journal-title":"Exp Ther Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"R6-20250504","first-page":"772","article-title":"Practice guidelines for patients with rheumatoid arthritis.","volume":"59","author":"Fang","year":"2020","journal-title":"Chin J Int Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis.","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard-2022-223358","article-title":"Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.","volume":"82","author":"Bergstra","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/ard-2022-223357","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.","volume":"82","author":"Sepriano","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R11-20250504","first-page":"55","article-title":"Clinical efficacy of modified Duhuo Jisheng decoction combined with methotrexate in treatment of patients with rheumatoid arthritis of active stage.","volume":"15","author":"Cao","year":"2020","journal-title":"China J Pharmac Econ"},{"key":"R12-20250504","first-page":"203","article-title":"Clinical research of Duhuo Jisheng decoction combined with meloxicam on treating rheumatoid arthritis.","volume":"19","author":"Chen","year":"2017","journal-title":"J Liaoning Univ TCM"},{"key":"R13-20250504","first-page":"1405","article-title":"Clinical efficacy of Duhuo Jisheng decoction combined with methotrexate in the treatment of rheumatoid arthritis.","volume":"13","author":"Guo","year":"2018","journal-title":"World Chin Med"},{"key":"R14-20250504","first-page":"63","article-title":"Clinical observation on the treatment of rheumatoid arthritis with modified Duhuo Parasitic Decoction.","volume":"8","author":"Huang","year":"2012","journal-title":"Asia-Pacific Trad Med"},{"key":"R15-20250504","first-page":"102","article-title":"Treatment for 29 patients with rheumatoid arthritis at active stage by DuHuo JiSheng Tang.","volume":"27","author":"Cao","year":"2014","journal-title":"Western J Trad Chin Med"},{"key":"R16-20250504","first-page":"106","article-title":"Influence of Duhuo Jisheng Tang on microcirculation and immunologic function of the patients with rheumatoid arthritis.","volume":"33","author":"Mei","year":"2020","journal-title":"Western J Trad Chin Med"},{"key":"R17-20250504","first-page":"1494","article-title":"Evaluation of clinical effect of modified Duhuo Jisheng Decoction combined with methotrexate in the treatment of rheumatoid arthritis with liver and kidney deficiency.","volume":"15","author":"Yang","year":"2020","journal-title":"World J Integr Trad Western Med"},{"key":"R18-20250504","first-page":"56","article-title":"Clinical observation on the treatment of 46 cases of rheumatoid arthritis with the combination of traditional Chinese and Western Medicine.","volume":"23","author":"Yu","year":"2014","journal-title":"Chin J Ethnomed Ethnopharm"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against rheumatism collaborative initiative.","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R23-20250504","first-page":"22","article-title":"Clinical efficacy of Duhuo Parasitic Decoction in the treatment of rheumatoid arthritis.","volume":"39","author":"Chen","year":"2020","journal-title":"Inner Mongol J Trad Chin Med"},{"key":"R25-20250504","first-page":"3671","article-title":"Effects of Duhuo Jisheng Decoction on bone repair of patients with rheumatoid arthritis patients.","volume":"15","author":"Chen","year":"2020","journal-title":"World Chin Med"},{"key":"R26-20250504","first-page":"71","article-title":"Evaluation of the therapeutic effect of Duhuo Parasitic Decoction combined with leflunomide in the treatment of elderly rheumatoid arthritis.","volume":"36","author":"Chen","year":"2017","journal-title":"Inner Mongol J Trad Chin Med"},{"key":"R27-20250504","first-page":"124","article-title":"Clinical observation of Duhuo Jisheng Decoction combined with iguratimod and hydroxychloroquine in the treatment of cold-dampness rheumatoid arthritis.","volume":"20","author":"Deng","year":"2022","journal-title":"Chin Med Mod Dist Educ China"},{"key":"R28-20250504","first-page":"972","article-title":"The effect of celecoxib capsule combined with angelicaepubescentis and loranthi pill on rheumatoid arthritis and levels of interleukin 6 and tumor necrosis factor \u03b1 in peripheral blood.","volume":"31","author":"Ding","year":"2021","journal-title":"Chin J Health Lab Technol"},{"key":"R29-20250504","first-page":"120","article-title":"The clinical effect of Duhuo Parasitic Decoction on rheumatoid arthritis patients and the influence of serum IL-1 \u03b2, IL-6 and TNF- \u03b1 levels.","volume":"26","author":"Gong","year":"2022","journal-title":"Med Forum"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13020-021-00510-6","article-title":"The Effectiveness of Duhuo Jisheng Decoction in treating rheumatoid arthritis and its effect on immune function of patients.","volume":"18","author":"He","year":"2021","journal-title":"Med Innov China"},{"key":"R31-20250504","first-page":"67","article-title":"Clinical observation of 78 cases of parasitic Decoction in the treatment of rheumatoid arthritis Guizhishaoyaozhimu Decoction and Angelica.","volume":"5","author":"Ji","year":"2015","journal-title":"China Med Pharm"},{"key":"R32-20250504","first-page":"738","article-title":"Observation on the therapeutic effect of Duhuo Parasitic Decoction combined with sulfasalazine in the treatment of 40 cases of rheumatoid arthritis.","volume":"49","author":"Jiang","year":"2014","journal-title":"Zhejiang J Trad Chin Med"},{"key":"R33-20250504","first-page":"1004","article-title":"Clinical observation of senile rheumatoid arthritis treated with traditional Chinese medicine Duhuo Jisheng Decoction combined with leflunomide.","volume":"34","author":"Li","year":"2012","journal-title":"Chin Trad Patent Med"},{"key":"R34-20250504","first-page":"56","article-title":"Clinical observation on the treatment of 30 cases of rheumatoid arthritis of liver and kidney deficiency type with modified Duhuo Parasitic Decoction combined with methotrexate","volume":"34","author":"Li","year":"2017","journal-title":"J Gansu Univ Chin Med"},{"key":"R36-20250504","first-page":"2798","article-title":"Influence of Duhuo Jisheng Decoction on rheumatoid arthritis patients and its effect on laboratory indicators.","volume":"33","author":"Ni","year":"2015","journal-title":"Chin Arch Trad Chin Med"},{"key":"R37-20250504","first-page":"173","article-title":"Clinical effect of Duhuo Jisheng Tang combined with meloxicam in treatment of rheumatoid arthritis.","volume":"22","author":"Qian","year":"2016","journal-title":"Chin J Exp Trad Med Formulae"},{"key":"R38-20250504","first-page":"2675","article-title":"Clinical efficacy of Duhuo Jisheng Decoction as adjuvant therapy for rheumatoid arthritis with liver-kidney deficiency pattern.","volume":"40","author":"Qiu","year":"2018","journal-title":"Guangxi Med J"},{"key":"R39-20250504","first-page":"374","article-title":"Clinical effect of Duhuo Parasitic Decoction on active rheumatoid arthritis and its impact on patient immune function.","volume":"13","author":"Shan","year":"2018","journal-title":"Intern Med"},{"key":"R40-20250504","first-page":"24","article-title":"Clinical observation of duhuojisheng soup in treatment of rheumatoid arthritis of liver and kidney deficiency type.","volume":"12","author":"Shi","year":"2019","journal-title":"Chin J Clin Rat Drug Use"},{"key":"R41-20250504","first-page":"112","article-title":"Clinical observation on the treatment of active rheumatoid arthritis with Duhuo Parasitic Decoction.","volume":"34","author":"Song","year":"2016","journal-title":"J Sichuan Trad Chin Med"},{"key":"R42-20250504","first-page":"71","article-title":"Clinical observation on Fangji Huangqi Decoction and Duhuo Jisheng Decoction in the treatment of rheumatoid arthritis.","volume":"18","author":"Wan","year":"2020","journal-title":"Chin Med Mod Dist Educ China"},{"key":"R43-20250504","first-page":"848","article-title":"Clinical observation on the treatment of rheumatoid arthritis with modified Duhuo Parasitic Decoction combined with methotrexate tablets.","volume":"36","author":"Wang","year":"2017","journal-title":"Gansu Med J"},{"key":"R44-20250504","first-page":"793","article-title":"Effect of Duhuo Jisheng decotion assisted treatment for rheumatoid arthritis.","volume":"17","author":"Wang","year":"2019","journal-title":"Chin J Gen Pract"},{"key":"R45-20250504","first-page":"82","article-title":"Clinical observation on treatment of 50 cases with rheumatoid arthritis by integrated Chinese and western medicine.","volume":"7","author":"Wang","year":"2015","journal-title":"Clin J Chin Med"},{"key":"R46-20250504","first-page":"59","article-title":"Effect of Duhuo Jisheng Decoction in the treatment of patients with rheumatoid arthritis.","volume":"19","author":"Wei","year":"2021","journal-title":"Chin For J Med Res"},{"key":"R47-20250504","first-page":"8","article-title":"Effect of Duhuo Jisheng Decoction on inflammatory cytokines in patients with rheumatoid arthritis.","volume":"8","author":"Xu","year":"2022","journal-title":"World J Composite Med"},{"key":"R49-20250504","first-page":"2560","article-title":"Clinical study of Duhuo Jisheng Decoction combined with meloxicam in treating rheumatoid arthritis.","volume":"24","author":"Yu","year":"2015","journal-title":"Mod J Int Trad Chin Western Med"},{"key":"R50-20250504","first-page":"108","article-title":"Efficacy of Methotrexate combined with Duhuo Jisheng decoction in treatment of rheumatoid arthritis.","volume":"31","author":"Zhang","year":"2019","journal-title":"Med J Chin People\u2019s Health"},{"key":"R51-20250504","first-page":"24","article-title":"On the treatment of 30 cases with rheumatoid arthritis due to liver and kidney deficiency by Duhuo Jisheng Decoction combined with Leflunomide.","volume":"2","author":"Zhang","year":"2013","journal-title":"Rheumatism Arthritis"},{"key":"R52-20250504","first-page":"800","article-title":"Study on the regulatory effect of Duhuo Parasitic Decoction on TH17\/Treg cell immune balance in the pathogenesis of rheumatoid arthritis.","volume":"37","author":"Zhang","year":"2018","journal-title":"Gansu Med J"},{"key":"R53-20250504","first-page":"5569","article-title":"The efficacy of Duhuo Parasitic Decoction combined with leflunomide in the treatment of elderly rheumatoid arthritis and its impact on joint function and inflammatory factors.","volume":"39","author":"Zhang","year":"2019","journal-title":"Chin J Gerontol"},{"key":"R54-20250504","first-page":"44","article-title":"Mechanism of Duhuo Parasitic Decoction in regulating the expression of inflammatory factors in intervention of bone destruction in patients with rheumatoid arthritis.","volume":"49","author":"Zhao","year":"2021","journal-title":"Acta Chin Med Pharmacol"},{"key":"R55-20250504","first-page":"8","article-title":"Effects of Duhuo Jisheng Decoction on Th17\/Treg balance in rheumatoid arthritis of liver-kidney insufficiency, cold-dampness obstruction pattern.","volume":"34","author":"Zhao","year":"2021","journal-title":"Western J Trad Chin Med"},{"key":"R57-20250504","first-page":"57","article-title":"Effect observation of modified Guizhi Shaoyao Zhimu Decoction in treatment of patients with gout in acute phase differentiated as type of cold- dampness obstruction.","volume":"24","author":"Bao","year":"2020","journal-title":"J Clin Med Pract"},{"key":"R58-20250504","first-page":"488","article-title":"Clinical study on the treatment of gout with Guizhi Shaoyao Zhimu Decoction combined with fepristone.","volume":"39","author":"Chen","year":"2018","journal-title":"Shaanxi J Trad Chin Med"},{"key":"R59-20250504","first-page":"103","article-title":"Observation on 45 cases of acute gouty arthritis treated by modified Guizhi Shaoyao Zhimu Decoction.","volume":"33","author":"He","year":"2015","journal-title":"J Sichuan Trad Chin Med"},{"key":"R60-20250504","first-page":"75","article-title":"The application of Guizhi Shaoyao Zhimu Decoction in gouty arthritis and its influence on serum IL-8 and TGF-\u03b2.","volume":"19","author":"He","year":"2021","journal-title":"Chin Med Mod Dist Educ China"},{"key":"R61-20250504","first-page":"326","article-title":"Observation for 30 cases of gouty arthritis treated with modified Jiawei Guizhi Shaoyao Zhimu Decoction.","volume":"19","author":"He","year":"2013","journal-title":"Chin J Exp Trad Med Formulae"},{"key":"R62-20250504","first-page":"56","article-title":"Improvement of VAS score, UA, CRP and ESR in patients with acute gout of cold and dampness syndrome treated by with Guizhi Shaoyao Zhimu decoction.","volume":"42","author":"Ji","year":"2021","journal-title":"J Med Forum"},{"key":"R63-20250504","first-page":"180","article-title":"Clinical efficacy of addition and subtraction treatment of Pingweisan combined with Guizhi Shaoyao Zhimu Tang for chronic gouty arthritis.","volume":"24","author":"Li","year":"2018","journal-title":"Chin J Exp Trad Med Formulae"},{"key":"R64-20250504","first-page":"108","article-title":"Clinical observation on the treatment of chronic gouty arthritis with Pingwei Powder and Guizhi Shaoyao Zhimu Decoction.","author":"Liu","year":"2022","journal-title":"One Health"},{"key":"R65-20250504","first-page":"177","article-title":"Clinical study on treatment of gouty arthritis with Guizhi Shaoyao Zhimu Decoction.","volume":"26","author":"Luo","year":"2017","journal-title":"Foot Health Care"},{"key":"R67-20250504","first-page":"167","article-title":"Clinical research on therapeutic effect of modified Guizhi Shaoyao Zhimu Decoction in treatment of Wind\u2013cold\u2013dampness Bi Syndrome in acute gouty arthritis.","volume":"32","author":"Shen","year":"2014","journal-title":"Chin Arch Trad Chin Med"},{"key":"R68-20250504","first-page":"237","article-title":"Observation on therapeutic effect of Guizhi Shaoyao Zhimu Decoction on gouty arthritis.","volume":"8","author":"Shi","year":"2012","journal-title":"Chin Med Guide"},{"key":"R69-20250504","first-page":"207","article-title":"To observe the clinical effect of modified Guizhishaoyaozhimu Decoction in the treatment of gouty arthritis.","volume":"7","author":"Wang","year":"2015","journal-title":"China Contin Med Educ"},{"key":"R71-20250504","first-page":"19","article-title":"Observation on 45 cases of acute gout treated with Guizhi Shaoyao Zhimu Decoction.","volume":"22","author":"Xu","year":"1998","journal-title":"J Zhejiang Univ Trad Chin Med"},{"key":"R72-20250504","first-page":"508","article-title":"45 cases of acute gouty arthritis of wind-cold dampness type treated by modified Guizhi Shaoyao Zhimu Decoction.","volume":"39","author":"Zhu","year":"2019","journal-title":"Henan Trad Chin Med"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.2018.21362","article-title":"Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: the IMAGINE-RA randomized clinical trial.","volume":"321","author":"M\u00f8ller-Bisgaard","year":"2019","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R74-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/oxfordjournals.rheumatology.a031490","article-title":"Prognostic factors in early rheumatoid arthritis.","volume":"39","author":"Scott","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis.","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat Immunol"},{"key":"R76-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2010.135509","article-title":"Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens.","volume":"70","author":"Suwannalai","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R77-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41584-022-00786-4","article-title":"From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis.","volume":"18","author":"Scherer","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R78-20250504","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/rheumatology\/keg381","article-title":"Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice.","volume":"42","author":"Tanaka","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","article-title":"Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R80-20250504","doi-asserted-by":"crossref","first-page":"617","DOI":"10.29271\/jcpsp.2020.06.617","article-title":"Diagnostic value of musculoskeletal ultrasound in rheumatoid finger arthritis.","volume":"30","author":"Wang","year":"2020","journal-title":"J Coll Physicians Surg Pak"},{"key":"R81-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2017.05.010","article-title":"Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives.","volume":"189","author":"Nakken","year":"2017","journal-title":"Immunol Lett"},{"key":"R82-20250504","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.clinthera.2013.09.015","article-title":"Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.","volume":"35","author":"Navarro-Mill\u00e1n","year":"2013","journal-title":"Clin Ther"},{"key":"R83-20250504","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semarthrit.2010.09.004","article-title":"Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.","volume":"41","author":"Pease","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R84-20250504","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.intimp.2012.10.005","article-title":"A bispecific antibody against IL-1\u03b2 and IL-17A is beneficial for experimental rheumatoid arthritis.","volume":"14","author":"Qi","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"R85-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.intimp.2014.04.018","article-title":"Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.","volume":"21","author":"Li","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"R86-20250504","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.intimp.2010.02.011","article-title":"Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.","volume":"10","author":"Moon","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"R87-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keg038","article-title":"The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes.","volume":"42","author":"Burger","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R88-20250504","first-page":"618","article-title":"Exploring the mechanism of Naringenin on the improvement of rheumatoid arthritis model rats based on Treg\/Th17 balance.","volume":"51","author":"Leng","year":"2023","journal-title":"Mod Med J"},{"key":"R89-20250504","first-page":"579","article-title":"Therapeutic effect and mechanism of sodium formononetin-3\u2032-sulphonate on collagen-induced rheumatoid arthritis.","volume":"52","author":"Shi","year":"2021","journal-title":"J China Pharmac Univ"},{"key":"R90-20250504","doi-asserted-by":"crossref","first-page":"116727","DOI":"10.1016\/j.jep.2023.116727","article-title":"Therapeutic effects of columbianadin from Angelicae Pubescentis radix on the progression of collagen-induced rheumatoid arthritis by regulating inflammation and oxidative stress.","volume":"316","author":"Chen","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R92-20250504","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1002\/mco2.219","article-title":"Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease.","volume":"4","author":"Lin","year":"2023","journal-title":"MedComm"},{"key":"R93-20250504","doi-asserted-by":"crossref","first-page":"154640","DOI":"10.1016\/j.phymed.2022.154640","article-title":"Osthole: A potential AMPK agonist that inhibits NLRP3 inflammasome activation by regulating mitochondrial homeostasis for combating rheumatoid arthritis.","volume":"110","author":"Jiang","year":"2023","journal-title":"Phytomedicine"},{"key":"R95-20250504","doi-asserted-by":"crossref","first-page":"681525","DOI":"10.3389\/fphar.2021.681525","article-title":"Anti-inflammatory and pro-apoptotic effects of 18beta-Glycyrrhetinic acid in vitro and in vivo models of rheumatoid arthritis.","volume":"12","author":"Feng","year":"2021","journal-title":"Front Pharmacol"},{"key":"R96-20250504","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/acs.jafc.9b00185","article-title":"Liquiritin from Glycyrrhiza uralensis attenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway.","volume":"67","author":"Zhai","year":"2019","journal-title":"J Agric Food Chem"},{"key":"R97-20250504","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijbiomac.2022.03.090","article-title":"Angelica sinensis polysaccharide improves rheumatoid arthritis by modifying the expression of intestinal Cldn5, Slit3 and Rgs18 through gut microbiota.","volume":"209","author":"Hu","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"R98-20250504","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s10753-021-01504-0","article-title":"Paeoniflorin suppresses rheumatoid arthritis development via modulating the Circ-FAM120A\/miR-671-5p\/MDM4 axis.","volume":"44","author":"Ma","year":"2021","journal-title":"Inflammation"},{"key":"R99-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1071\/FP18080","article-title":"The effects of total glucosides of paeony (TGP) and paeoniflorin (Pae) on inflammatory-immune responses in rheumatoid arthritis (RA).","volume":"46","author":"Zhang","year":"2019","journal-title":"Funct Plant Biol"},{"key":"R100-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopha.2018.06.130","article-title":"Paeoniflorin inhibits Rho kinase activation in joint synovial tissues of rats with collagen-induced rheumatoid arthritis.","volume":"106","author":"Zhai","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R101-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/DDDT.S153927","article-title":"Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis.","volume":"12","author":"Yang","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"R102-20250504","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3892\/etm.2015.2908","article-title":"Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2.","volume":"11","author":"Jia","year":"2016","journal-title":"Exp Ther Med"},{"key":"R103-20250504","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbrc.2020.03.164","article-title":"Paeoniflorin-6\u2019-O-benzene sulfonate down-regulates CXCR4-G\u03b2\u03b3-PI3K\/AKT mediated migration in fibroblast-like synoviocytes of rheumatoid arthritis by inhibiting GRK2 translocation.","volume":"526","author":"Wang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R104-20250504","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/bph.12131","article-title":"an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.","volume":"169","author":"Aggarwal","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R105-20250504","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbapap.2015.12.010","article-title":"Identification of candidate synovial membrane biomarkers after Achyranthes aspera treatment for rheumatoid arthritis.","volume":"1864","author":"Zheng","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R106-20250504","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/ph14080776","article-title":"Inhibitory effects of IL-6-mediated matrix metalloproteinase-3 and -13 by Achyranthes japonica Nakai root in osteoarthritis and rheumatoid arthritis mice models.","volume":"14","author":"Zhao","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R107-20250504","doi-asserted-by":"crossref","first-page":"e114416","DOI":"10.1016\/j.biopha.2023.114416","article-title":"The prepared and characterized polysaccharide polymer in Saposhnikovia divaricata(Trucz) Schischk effectively controls the course of rheumatoid arthritis via TLR4\/TRAF6\u2013NF-\u03baB\/I\u03baB-\u03b1 signaling pathway.","volume":"160","author":"Xialin","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R108-20250504","first-page":"2791","article-title":"Inhibitory effect of Saposhnikovia divaricate polysaccharide on fibroblast-like synoviocytes from rheumatoid arthritis rat in vitro.","volume":"31","author":"Ci","year":"2018","journal-title":"Pak J Pharm Sci"},{"key":"R109-20250504","doi-asserted-by":"crossref","first-page":"115184","DOI":"10.1016\/j.ab.2023.115184","article-title":"Research on the improvement effect of Saposhnikovia divaricata (Trucz) Schischk on rheumatoid arthritis based on the \u201ccomponent-target-pathway\u201d association.","volume":"674","author":"Liu","year":"2023","journal-title":"Anal Biochem"},{"key":"R110-20250504","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard-2023-223901","article-title":"Rheumatoid factor autoantibody repertoire profiling reveals distinct binding epitopes in health and autoimmunity.","volume":"82","author":"Oskam","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R111-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/biomedicines10030558","article-title":"Frequency and clinical significance of elevated IgG4 in rheumatoid arthritis: a systematic review.","volume":"10","author":"Sakthiswary","year":"2022","journal-title":"Biomedicines"},{"key":"R112-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.imlet.2017.08.023","article-title":"Functional complement activity is decisive for the development of chronic synovitis, osteophyte formation and processes of cell senescence in zymosan-induced arthritis.","volume":"190","author":"Ganova","year":"2017","journal-title":"Immunol Lett"},{"key":"R113-20250504","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis.","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"R114-20250504","first-page":"32","article-title":"Functional mechanism of Duhuo Jisheng Decoction (\u72ec\u6d3b\u5bc4\u751f\u6c64) on pyroptosis of chondrocyte in rheumatoid arthritis based on the NLRP3\/Caspase-1 signaling pathwaw.","volume":"23","author":"Peng","year":"2021","journal-title":"J Liaoning Univ TCM"},{"key":"R115-20250504","first-page":"3929","article-title":"Preparation of Sanwujiao extract-hydrogel and its therapeutic effect on rheumatoid arthritis.","volume":"53","author":"Xiao","year":"2022","journal-title":"Chin Trad Herbal Drugs"},{"key":"R116-20250504","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis.","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"R117-20250504","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/ard.2004.033332","article-title":"Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.","volume":"64","author":"Verburg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R118-20250504","doi-asserted-by":"crossref","first-page":"e002563","DOI":"10.1136\/rmdopen-2022-002563","article-title":"Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium.","volume":"8","author":"Murray-Brown","year":"2022","journal-title":"RMD Open"},{"key":"R119-20250504","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis.","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"R120-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis - shaping the immunological landscape.","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R121-20250504","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis.","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann Intern Med"},{"key":"R122-20250504","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","article-title":"Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.","volume":"73","author":"Kleyer","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R123-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13075-018-1515-1","article-title":"Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX\u00ae: a registry study of RA with osteoporosis\/fracture.","volume":"20","author":"Cheng","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R124-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13075-017-1457-z","article-title":"Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis.","volume":"19","author":"Jin","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R125-20250504","first-page":"370","article-title":"Prevalence and influencing factors of sarcopenia in patients with fragility fracture: a systematic review.","volume":"15","author":"Zhang","year":"2022","journal-title":"Chin J Osteoporos Bone Miner Res"},{"key":"R126-20250504","first-page":"1666","article-title":"Fractures in rheumatoid arthritis: an evaluation of associated risk factors.","volume":"20","author":"Michel","year":"1993","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"R128-20250504","doi-asserted-by":"crossref","first-page":"ii84","DOI":"10.1136\/ard.61.suppl_2.ii84","article-title":"Bone destruction in arthritis.","volume":"61","author":"Gravallese","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R129-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","article-title":"Rheumatic diseases: the effects of inflammation on bone.","volume":"208","author":"Walsh","year":"2005","journal-title":"Immunol Rev"},{"key":"R130-20250504","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00132-019-03809-3","article-title":"[Rheumatism and bone metabolism] Rheuma und Knochenstoffwechsel.","volume":"48","author":"Dischereit","year":"2019","journal-title":"Orthopade"},{"key":"R132-20250504","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.3390\/nu13103535","article-title":"Improvement of inflammation and pain after three months\u2019 exclusion diet in rheumatoid arthritis patients.","volume":"13","author":"Guagnano","year":"2021","journal-title":"Nutrients"},{"key":"R133-20250504","doi-asserted-by":"crossref","first-page":"e0257200","DOI":"10.1371\/journal.pone.0257200","article-title":"Platelet indices parameters in the new disease activity score of rheumatoid arthritis with ankle involvement: a comparative analytic study.","volume":"16","author":"Khaled","year":"2021","journal-title":"PLoS One"},{"key":"R134-20250504","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s10067-019-04574-6","article-title":"The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis.","volume":"38","author":"Ruiz-Medrano","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R135-20250504","first-page":"28","article-title":"Meta-analysis of the curative effect of Duhuo Jisheng Tang combined with western medicine on rheumatoid arthritis.","volume":"8","author":"Zhang","year":"2019","journal-title":"Rheumatism Arthritis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:18:14Z","timestamp":1746325094000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":125,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035513","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}